Related Experiment Video
Updated: Feb 6, 2026

Analysis of Histone Antibody Specificity with Peptide Microarrays
Published on: August 1, 2017
Antibody characterization using novel ERLIC-MS/MS-based peptide mapping
Jing Zhen1, John Kim1, Ying Zhou1
1a Department of Analytical Sciences and Operations , Biologics CMC, Teva Pharmaceutical Industries , West Chester , PA , USA.
Electrostatic repulsion hydrophilic interaction chromatography (ERLIC) coupled with mass spectrometry (MS) offers a novel peptide mapping method for biologic therapeutics. This technique provides superior sequence coverage and characterization of challenging modifications like asparagine deamidation.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Proteomics
Background:
- Electrostatic repulsion hydrophilic interaction chromatography (ERLIC) coupled with mass spectrometry (MS) is gaining traction in proteomics.
- ERLIC is utilized for glycopeptide/phosphorylated peptide enrichment and sample fractionation.
Purpose of the Study:
- To introduce a novel ERLIC-MS/MS peptide mapping method for biologic therapeutics characterization.
- To evaluate ERLIC's performance against traditional reversed-phase liquid chromatography (RPLC)-MS/MS.
Main Methods:
- Development and application of an ERLIC-MS/MS based peptide mapping strategy.
- Characterization of denosumab, focusing on sequence coverage, terminal peptides, methionine oxidation, asparagine deamidation, and glycopeptides.
Main Results:
- Achieved 100% sequence coverage for denosumab light and heavy chains, outperforming RPLC-MS/MS for small peptides.
- Demonstrated superior separation and characterization of asparagine deamidated peptides, a known RPLC-MS/MS challenge.
- Successfully extended ERLIC applications from sample preparation to direct characterization of biologic therapeutics.
Conclusions:
- The developed ERLIC-MS/MS method is effective for denosumab characterization, offering complete sequence coverage.
- ERLIC-MS/MS serves as a valuable standalone or orthogonal method to RPLC-MS/MS for monoclonal antibody characterization.
- This approach enhances the reliability and confidence in bottom-up peptide mapping for biologic therapeutics analysis.
Related Concept Videos
Peptide Bonds
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Microtubule Associated Proteins (MAPs)
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Plotting of Topographic Maps
Coordinates and Map Projections

